Work

Frontline Brentuximab Vedotin Plus Cyclophosphamide, Doxorubicin and Prednisone in Patients with Peripheral T-Cell Lymphoma with Less Than 10% CD30 Expression (SGN35-032, Trial in Progress)

Year: 2021

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2021-151645

Authors: Deepa Jagadeesh, Scott Knowles, Steven M. Horwitz

Institutions: Cleveland Clinic, Case Comprehensive Cancer Center, Seagen (United States), Memorial Sloan Kettering Cancer Center

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3211340516

Cites:

Cited by: 1

Related to: 10